Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Virax Biolabs Group Ltd VRAX

Healthcare
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VRAX)

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

PR Newswire October 23, 2024

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

PR Newswire September 16, 2024

Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference

PR Newswire September 9, 2024

Virax Biolabs to Participate at 7th European Congress of Immunology

PR Newswire August 29, 2024

Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

PR Newswire August 28, 2024

Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

PR Newswire August 23, 2024

Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares

PR Newswire August 21, 2024

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

PR Newswire April 25, 2024

Virax Biolabs to Participate at ESCMID Global 2024

PR Newswire April 16, 2024
View More News ››

Opinion & Analysis (NDAQ:VRAX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VRAX)

MonkeyPox Breaking News! VRAX Halted UP

MonkeyPox Breaking News! VRAX Halted UP
10QKing - August 21, 2024

RE:RE:RE:marburg virus news...

Tweet   ...
rich39 - May 24, 2023

RE:RE:marburg virus news...

    ...
rich39 - May 24, 2023

RE:marburg virus news...

rnda ...
rich39 - May 24, 2023

marburg virus news...

Tweet   ...
rich39 - May 24, 2023

waking up...

eom
rich39 - May 18, 2023
View more Bullboard ››

Southern Silver Exploration Corp.

Southern Silver Exploration Corp.

Southern Silver Exploration Corp is a Canadian company engaged in the acquisition, exploration, and development of natural ...
View More »